Skip to main content
News

Estrogen Patch Recalled


July 17, 2017

A defective delivery system is prompting Noven Pharmaceuticals Inc. to voluntarily recall 14,434 cartons of Minivelle (estradiol transdermal system) 0.1 mg per day, according to the July 5, 2017, US Food and Drug Administration (FDA) Enforcement Report.

Each carton contains 8 Minivelle systems. Affected products are from lot 78618, which had a May 2017 expiration. The lot was distributed across the country.

______________________________________________________
Related Content
Class II Hormone Recall
ACP Releases Updated Osteoporosis Guidelines
______________________________________________________

Noven Pharmaceuticals issued the voluntary recall April 27, 2017. On June 23, 2017, the FDA classified the recall as Class III, indicating that use of the affected products is unlikely to cause adverse health consequences.

Minivelle is a prescription-only estrogen therapy patch for the treatment of hot flashes, night sweats, and other symptoms of menopause.

Jolynn Tumolo

Back to Top